Fox Run Management’s Artivion AORT Stock Holding History

Fox Run Management’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,008	Closed	-$390K	–	913
2026 Q1	$390K	Buy	+11,008	New	+$434K	0.07%	541

Other funds holding AORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Fox Run Management's AORT Position: Q2 2026 in Review

Fox Run Management sold out of Artivion (AORT) in Q2 2026, closing a stake of 11,008 shares — an estimated $390K sold.

Fox Run Management first reported a position in AORT in Q1 2026 and held it in 1 quarter. The position peaked at $390K in Q1 2026. 207 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

Fox Run Management reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
Fox Run Management sold 11,008 Artivion shares in Q2 2026, an estimated $390K.
Fox Run Management first reported a position in Artivion in Q1 2026 and held it in 1 quarter.
Fox Run Management's Artivion position peaked at $390K in Q1 2026.
207 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.